MAPK3 and cardiac hypertrophy: However, the absence of synergistic effects on ERK1/2 and TLR4 by the combination treatment, suggests these two signalings may represent distinct signaling routes for Sal B and Sen I, while MAP3K1 appears to serve as a converging node mediating their cooperative actions in modulating cardiac hypertrophy.